Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Jones, Stephanie A ^a,b   Groome, Michelle ^a,b   Koen, Anthonet ^a,b   Van Niekerk, Nadia ^a,b   Sewraj, Poonam ^a,b   Kuwanda, Locadiah ^a,b   Izu, Alane ^a,b   Adrian, Peter V ^a,b   Madhi, Shabir A ^a,b,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEBERBIOVAC; IMMUNOGLOBULIN G; MEASLES VACCINE; MERIEUX; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; RECOMBINANT HEPATITIS B VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

AGE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CHILD; COHORT ANALYSIS; DOSAGE SCHEDULE COMPARISON; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; LONGITUDINAL STUDY; MALE; NORMAL HUMAN; OPSONIZATION; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SEROTYPE; SOUTH AFRICA;

ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; FEMALE; HUMANS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; SOUTH AFRICA; TIME FACTORS;

EID: 84883348093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072794     Document Type: Article

References (25)

1. World Health Organization (2012) Pneumococcal vaccines WHO position paper-2012. Wkly Epidemiol Rec 87: 129-144.
2. Scott P, Rutjes AW, Bermetz L, Robert N, Scott S, et al. (2011) Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis. Vaccine 29: 9711-9721. doi:10.1016/j.vaccine.2011.07.042. PubMed: 21821080.
3. Rückinger S, Dagan R, Albers L, Schönberger K, von Kries R, (2011) Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: a systematic review and meta-analysis. Vaccine 29: 9600-9606. doi:10.1016/j.vaccine.2011.09.011. PubMed: 21933696.
4. Goldblatt D, Southern J, Ashton L, Andrews N, Woodgate S, et al. (2010) Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom. Pediatr Infect Dis J 29: 401-405. doi:10.1097/INF.0b013e3181c67f04. PubMed: 20010312.
5. Black S, Shinefield H, Fireman B, Lewis E, Ray P, et al. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19: 187-195.
6. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349: 1341-1348. doi:10.1056/NEJMoa035060. PubMed: 14523142.
7. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 1139-1146. doi:10.1016/S0140-6736(05)71876-6. PubMed: 15794968.
8. Madhi SA, Adrian P, Kuwanda L, Jassat W, Jones S, et al. (2007) Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine 25: 2451-2457. doi:10.1016/j.vaccine.2006.09.019. PubMed: 17023095.
9. Nunes MC, von Gottberg A, de Gouveia L, Cohen C, Moore DP, et al. (2011) The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS 25: 453-462. doi:10.1097/QAD.0b013e328341b7f1. PubMed: 21178754.
10. Madhi SA, Klugman KP, Kuwanda L, Cutland C, Käyhty H, et al. (2009) Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis 199: 1168-1176. doi:10.1086/597388. PubMed: 19265481.
11. Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, et al. (1997) Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 4: 415-422. PubMed: 9220157.
12. Jódar L, Butler J, Carlone G, Dagan R, Goldblatt D, et al. (2003) Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21: 3265-3272. doi:10.1016/S0264-410X(03)00230-5. PubMed: 12804857.
13. Madhi SA, Adrian P, Cotton MF, McIntyre JA, Jean-Philippe P, et al. (2010) Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis, 202: 355-361. doi:10.1086/653704. PubMed: 20583920.
14. Madhi SA, Izu A, Violari A, Cotton MF, Panchia R, et al. (2013) Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and-uninfected infants. Vaccine 31: 777-783. doi:10.1016/j.vaccine.2012.11.076. PubMed: 23228814.
15. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349: 1341-1348. doi:10.1056/NEJMoa035060. PubMed: 14523142.
16. Dagan R, Givon-Lavi N, Porat N, Greenberg D, (2012) The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with a 7-valent pneumococcal conjugate vaccine on a pneumococcal carriage: a randomized controlled trial. Vaccine 30: 1532-1540.
17. Silberbauer EJ, Ismail N, Von Gottberg A, Hoosen AA, (2011) Serotype and antimicrobial profile distribution of invasive pneumococcal isolated in the pre-vaccine introduction era in Pretoria, South Africa, 2005-2009. Diagn Microbiol Infect Dis 71: 309-311. doi:10.1016/j.diagmicrobio.2011.07.006. PubMed: 21907527.
18. Dagan R, Poolman JT, Zepp F, (2008) Combination vaccines containing DTaP-Hib: impact of IPV and coadninistration of CRM197 conjugates. Expert Rev Vaccines 7: 97-115. doi:10.1586/14760584.7.1.97. PubMed: 18251697.
19. Dagan R, Goldblatt D, Maleckar JR, Yaïch M, Eskola J, (2004) Reduction of Antibody Response to an 11-Valent Pneumococcal Vaccine Coadministered with a Vaccine Containing Acellular Pertussis Components. Infect Immun 72: 5383-5391. doi:10.1128/IAI.72.9.5383-5391.2004. PubMed: 15322036.
20. Schmitt HJ, Faber J, Lorenz I, Schmöle-Thoma B, Ahlers N, (2003) The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine. Vaccine 21: 3653-3662. doi:10.1016/S0264-410X(03)00389-X. PubMed: 12922095.
21. Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ, (2006) The immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTaP-HBV-IPV/Hib combination vaccine in healthy infants. Vaccine 24: 4727-4736. doi:10.1016/j.vaccine.2006.03.032. PubMed: 16616973.
22. Knuf M, Szenborn L, Moro M, Petit C, Bermal N, et al. (2009) Immunogenicity of Rountiely Used Chilhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typable Heamophilus influenzae Protein D Conjugate Vaccine (PHiD-CV). Pediatr Infect Dis J 28: S97-S108. doi:10.1097/INF.0b013e318199f61b. PubMed: 19325452.
23. Madhi SA, Cohen C, von Gottberg A, (2012) Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine 7 (Suppl 3):: C21-C27. PubMed: 22939016.
24. Madhi SA, Groome M, Zar H, Kapongo C, Mulligan C, et al. (2012) Effectiveness of Pneumococcal Conjugate Vaccine against presumed bacterial pneumonia (PBP) in South African HIV-uninfected children: A Case-Contril Study. Abstract 304: In: Abstracts: 8th International Symposium on Pneumococci and Pneumococcal Diseases. Igacu Falls, Brazil, March 11-15 2012.
25. Mahdi SA, (2012) Out of Africa: Lessons Learnt and Challenges in Evaluating the Effectivementt of Pneumococcal Conjugate Vaccine. Abstract 16: In: Abstracts: 8th International Symposium on Pneumococci and Pneumococcal Diseases. Igacu Falls, Brazil, March 11-15 2012.